Narrow your search

Library

KU Leuven (2)

Odisee (2)

Thomas More Kempen (2)

Thomas More Mechelen (2)

UCLL (2)

ULB (2)

ULiège (2)

VIVES (2)

UGent (1)


Resource type

book (2)


Language

English (2)


Year
From To Submit

2018 (1)

2012 (1)

Listing 1 - 2 of 2
Sort by

Book
Minimal residual disease and circulating tumor cells in breast cancer
Authors: --- ---
ISBN: 3642281591 364244587X 3642281605 1280799994 9786613710383 Year: 2012 Publisher: Heidelberg, Germany : Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Most deaths from carcinomas are caused by the hematogenous dissemination of cancer cells to distant organs and the eventual development of metastases. When found in the bone marrow or peripheral blood of carcinoma patients, occult cancer cells are referred to as disseminated tumor cells (DTCs) or circulating tumor cells (CTCs). CTCs and DTCs are considered surrogates of minimal residual disease, i.e., the presence of malignant cells in distant organs that are undetectable by conventional imaging and laboratory tests used for tumor staging after curative surgery of the primary tumor.   In this book, leading investigators in the field provide up-to-date information on a series of important questions, including:   -  How can the study of minimal residual disease and CTCs help us to better understand breast cancer metastasis? -  What technologies are available for the detection and characterization of CTCs and DTCs, and what are their relative merits? -  How are DTCs and CTCs relevant to clinical research and practice? - What is the role of other blood-based biomarkers such as circulating endothelial cells and circulating nucleic acids? -  What are the challenges in drug and biomarker co-development and the use of CTCs for companion diagnostic development?   This book will be of interest and assistance to all who are engaged in the modern management of breast cancer.


Book
Biological Mechanisms of Minimal Residual Disease and Systemic Cancer
Author:
ISBN: 3319977466 3319977458 Year: 2018 Publisher: Cham : Springer International Publishing : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

This book focuses on the biological mechanisms of minimal residual disease (MRD) and recurrence. It integrates this biology in solid cancers and in hematological malignancies. It reports also on technological advancements for monitoring MRD, derived from mechanistic insights. Chapters in solid and hematological malignancies address stem cell biology, genetics, epigenetics and micro-environmental regulation of dormant MRD. Novel insight into technologies for molecular phenotyping of MRD and monitoring of CTCs, DTCs and cell free RNA and DNA are also addressed extensively. Five chapters explore the above concepts in solid cancers such as prostate, breast, melanoma, head and neck and esophageal. Two chapters also explore the basic mechanisms of vascular biology targeting and epigenetic mechanisms regulating pluripotency programs during dormancy. Similar biology is explored in hematological malignancies such as T-ALL, CML, AML and multiple myeloma in additional four chapters. This book is edited and prefaced by Dr. Julio Aguirre-Ghiso, an expert in dormancy and recurrence. The chapters are written by world-recognized experts Drs. Ravi Bahtia, Samir Parekh, Russel Taichman, Monica Guzman, David Hoon, Denis Schewe, Irmela Jeremias, Cyrus Ghajar, Maria Soledad Sosa and Nicholas Stoecklein. The topic of this book is of particular interest to both basic cancer cell biologists and physician scientists that are working to provide a more integrated view of the biology of MRD and to those interested in working on or learning about this paradigm. The integrated and cross-disciplinary focus of the book from biology to medicine seeks to help bridge gaps to improve cancer care and prevent recurrences.

Listing 1 - 2 of 2
Sort by